Price to Sales (P/S)
since 2005
Calculation
Cytokinetics Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenues1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | 43.37 | = | 43.11 | ÷ | 0.99 | 0.99 | = | 94,588 | ÷ | 95,161,391 | |
| Feb 25, 2022 | 42.19 | = | 35.02 | ÷ | 0.83 | 0.83 | = | 70,428 | ÷ | 84,856,037 | |
| Feb 26, 2021 | 23.86 | = | 18.73 | ÷ | 0.79 | 0.79 | = | 55,828 | ÷ | 71,110,576 | |
| Mar 4, 2020 | 32.88 | = | 14.86 | ÷ | 0.45 | 0.45 | = | 26,868 | ÷ | 59,450,437 | |
| Mar 7, 2019 | 10.47 | = | 6.01 | ÷ | 0.57 | 0.57 | = | 31,501 | ÷ | 54,888,369 | |
| Mar 5, 2018 | 33.73 | = | 8.35 | ÷ | 0.25 | 0.25 | = | 13,368 | ÷ | 54,008,113 | |
| Mar 6, 2017 | 4.65 | = | 11.85 | ÷ | 2.55 | 2.55 | = | 106,407 | ÷ | 41,729,549 | |
| Mar 3, 2016 | 8.98 | = | 6.50 | ÷ | 0.72 | 0.72 | = | 28,658 | ÷ | 39,592,808 | |
| Mar 6, 2015 | 6.43 | = | 7.80 | ÷ | 1.21 | 1.21 | = | 46,940 | ÷ | 38,674,892 | |
| Mar 7, 2014 | 12.02 | = | 10.21 | ÷ | 0.85 | 0.85 | = | 30,648 | ÷ | 36,078,367 | |
| Mar 15, 2013 | 20.07 | = | 6.30 | ÷ | 0.31 | 0.31 | = | 7,559 | ÷ | 24,077,245 | |
| Mar 13, 2012 | 22.34 | = | 7.02 | ÷ | 0.31 | 0.31 | = | 4,000 | ÷ | 12,729,467 | |
| Mar 11, 2011 | 39.47 | = | 9.12 | ÷ | 0.23 | 0.23 | = | 2,577 | ÷ | 11,151,683 | |
| Mar 11, 2010 | 2.57 | = | 20.16 | ÷ | 7.83 | 7.83 | = | 81,538 | ÷ | 10,410,819 | |
| Mar 12, 2009 | 8.57 | = | 12.00 | ÷ | 1.40 | 1.40 | = | 12,420 | ÷ | 8,869,882 | |
| Mar 12, 2008 | 11.18 | = | 18.54 | ÷ | 1.66 | 1.66 | = | 13,622 | ÷ | 8,216,883 | |
| Mar 12, 2007 | 112.43 | = | 45.06 | ÷ | 0.40 | 0.40 | = | 3,127 | ÷ | 7,802,005 | |
| Mar 10, 2006 | 28.53 | = | 42.90 | ÷ | 1.50 | 1.50 | = | 8,912 | ÷ | 5,927,659 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Cytokinetics Inc. Annual Report.
Comparison to Competitors
Cytokinetics Inc., P/S, long-term trends, comparison to competitors
| Cytokinetics Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | 43.37 | 4.61 | 5.17 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 4.71 | 2.37 | 7.01 | 4.73 |
| Feb 25, 2022 | 42.19 | 4.53 | 5.10 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.96 | 3.18 | 4.20 | 5.39 |
| Feb 26, 2021 | 23.86 | 4.05 | 5.64 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 4.50 | 6.24 | 5.52 |
| Mar 4, 2020 | 32.88 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | 3.66 | 5.34 | 4.83 |
| Mar 7, 2019 | 10.47 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | 4.49 | 6.62 | 4.24 |
| Mar 5, 2018 | 33.73 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | 4.05 | 5.92 | 4.01 |
| Mar 6, 2017 | 4.65 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | 3.84 | 7.86 | 3.37 |
| Mar 3, 2016 | 8.98 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | 3.76 | 9.38 | 3.05 |
| Mar 6, 2015 | 6.43 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | 4.24 | 14.62 | 3.06 |
| Mar 7, 2014 | 12.02 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | 3.97 | 15.52 | 3.74 |
| Mar 15, 2013 | 20.07 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | 3.34 | 11.66 | 2.12 |
| Mar 13, 2012 | 22.34 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | 2.37 | 20.90 | 1.77 |
| Mar 11, 2011 | 39.47 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | 2.27 | 7.38 | 2.00 |
| Mar 11, 2010 | 2.57 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | 2.83 | 5.74 | 1.98 |
| Mar 12, 2009 | 8.57 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | 1.72 | 5.17 | 1.44 |
| Mar 12, 2008 | 11.18 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | 3.11 | 11.94 | 2.40 |
| Mar 12, 2007 | 112.43 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | 3.67 | 19.70 | 5.05 |
| Mar 10, 2006 | 28.53 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | 3.77 | 14.06 | 2.15 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Cytokinetics Inc., P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Cytokinetics Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Mar 1, 2023 | 43.37 | 4.50 |
| Feb 25, 2022 | 42.19 | 4.45 |
| Feb 26, 2021 | 23.86 | 4.85 |
| Mar 4, 2020 | 32.88 | 4.76 |
| Mar 7, 2019 | 10.47 | 4.44 |
| Mar 5, 2018 | 33.73 | 4.51 |
| Mar 6, 2017 | 4.65 | 4.24 |
| Mar 3, 2016 | 8.98 | 4.05 |
| Mar 6, 2015 | 6.43 | 4.46 |
| Mar 7, 2014 | 12.02 | 4.25 |
| Mar 15, 2013 | 20.07 | 3.24 |
| Mar 13, 2012 | 22.34 | 2.56 |
| Mar 11, 2011 | 39.47 | 2.41 |
| Mar 11, 2010 | 2.57 | 2.96 |
| Mar 12, 2009 | 8.57 | 2.20 |
| Mar 12, 2008 | 11.18 | 3.18 |
| Mar 12, 2007 | 112.43 | 3.87 |
| Mar 10, 2006 | 28.53 | 3.82 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cytokinetics Inc., P/S, long-term trends, comparison to industry (health care)
| Cytokinetics Inc. | Health Care | |
|---|---|---|
| Mar 1, 2023 | 43.37 | 33,555.66 |
| Feb 25, 2022 | 42.19 | 2.26 |
| Feb 26, 2021 | 23.86 | 2.20 |
| Mar 4, 2020 | 32.88 | 2.12 |
| Mar 7, 2019 | 10.47 | 2.32 |
| Mar 5, 2018 | 33.73 | 2.30 |
| Mar 6, 2017 | 4.65 | 2.12 |
| Mar 3, 2016 | 8.98 | 2.10 |
| Mar 6, 2015 | 6.43 | 2.38 |
| Mar 7, 2014 | 12.02 | 2.17 |
| Mar 15, 2013 | 20.07 | 1.73 |
| Mar 13, 2012 | 22.34 | 1.55 |
| Mar 11, 2011 | 39.47 | 1.46 |
| Mar 11, 2010 | 2.57 | 1.64 |
| Mar 12, 2009 | 8.57 | 1.36 |
| Mar 12, 2008 | 11.18 | 2.01 |
| Mar 12, 2007 | 112.43 | 2.43 |
| Mar 10, 2006 | 28.53 | 2.72 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).